Dominant presence across MSCA-IF, MSCA-RISE, and MSCA-COFUND programmes including EI3POD, WIRL, and SPARK, hosting or partnering in 11 mobility-related projects.
MONASH UNIVERSITY
Australia's leading H2020 partner university, contributing specialist research across health, materials science, astrophysics, and researcher mobility programmes.
Their core work
Monash University is one of Australia's leading research-intensive universities, contributing deep specialist expertise to European research consortia across a remarkably wide range of disciplines — from biomedical sciences and cancer biology to astrophysics, materials science, and digital humanities. In H2020, Monash primarily serves as a non-EU partner or third-party host for researcher mobility programmes (Marie Skłodowska-Curie Actions), providing world-class facilities and supervision for European researchers undertaking international fellowships. Their participation reflects strong individual research groups rather than a single institutional strategy, spanning health (autoimmunity, diabetes prevention, prostate cancer), earth sciences (geomaterials), fundamental physics (particle simulations, planet formation), and emerging 2D materials research.
What they specialise in
Projects spanning autoimmune disease (RELENT), prostate cancer plasticity (PDX-PC), gestational diabetes prevention (IMPACT DIABETES B2B), digital health tools (DigiCare4You), and preterm birth outcomes (TVPIPD).
Contributed to planet formation modelling in DUSTBUSTERS and astronomical survey selection in GaiaUnlimited.
Research on geomaterial stabilisation for infrastructure (GeoRes) and 2D transition metal dichalcogenide heterostructures (2DTWISTMDs).
Participated in THOR and FREYA, both focused on open research data infrastructure and persistent identifier systems.
PLATYPUS project investigating how sensorimotor interactions shape visual perception and eye movement control.
How they've shifted over time
In the early period (2015–2018), Monash's H2020 involvement centred on open research infrastructure (THOR, FREYA), chronic autoimmune disease research (RELENT), and hosting postdoctoral mobility fellows through MSCA-COFUND programmes — reflecting an institutional push to integrate into European research networks. From 2019 onward, the focus shifted toward applied health challenges like diabetes prevention screening and cancer treatment resistance, alongside new directions in advanced materials (2D heterostructures), evolutionary biology (land plant reproduction), and digital humanities (music score technology). The portfolio has become more diverse and application-oriented, moving from predominantly training-and-infrastructure roles toward substantive research contributions in specific domains.
Monash is shifting from primarily hosting mobility fellows toward deeper research partnerships in applied health (diabetes, cancer) and materials science, suggesting future collaborations should target these growing strengths.
How they like to work
Monash never coordinates H2020 projects — it joins as a third-party partner (15 of 22 projects) or participant (7), which is typical for a non-EU institution bringing complementary expertise to European-led consortia. With 201 unique partners across 33 countries, they operate as a well-connected hub rather than a loyal repeat-partner organisation, engaging with a different set of collaborators on nearly every project. This breadth means they are easy to approach for new consortia, but prospective partners should expect Monash to contribute specialist research capacity rather than project management or coordination.
Monash has built an exceptionally broad European network with 201 unique consortium partners across 33 countries — far-reaching for a non-EU institution. Their connections span nearly every major EU research nation, reflecting their role as a go-to Australian partner for diverse European consortia.
What sets them apart
As Australia's most active H2020 participant, Monash offers European consortia something few partners can: a bridge to the Asia-Pacific research ecosystem combined with world-class facilities across multiple disciplines. Their value lies not in project leadership but in providing complementary non-EU expertise that strengthens international dimension requirements — a criterion increasingly important in Horizon Europe proposals. For consortium builders, Monash is a reliable, low-friction partner with proven experience navigating EU framework programme requirements from outside Europe.
Highlights from their portfolio
- IMPACT DIABETES B2BLarge-scale implementation action for gestational diabetes prevention using mHealth tools — one of Monash's most applied and health-impact-focused H2020 engagements.
- DigiScoreThe only project with recorded EC funding to Monash (€118,799), investigating how computational technology transforms musical performance practice — an unusual digital humanities direction.
- GeoResFive-year MSCA-RISE project on waste-to-resource geomaterials for infrastructure, combining environmental remediation with civil engineering applications.